Grant: Idea to Innovation
University of Victoria
$20,000.00
Development of HeartPrint Bioink
FY 2021-22
Summary
3D bioprinting enables to generation of human tissue models for screening potential drug targets in a more relevant fashion compared to animal models. Animal models fail to predict the toxicity of potential drug targets on cardiovascular system, including the heart. 40% of drugs that enter clinical trials fail as a result of unexpected cardiotoxicity. Thus, a huge market exists for a bioink capable of printing human cardiac tissues that can be used to screen potential drugs for this issue. This project will upon our team's expertise in producing TissuePrint and BrainPrint to perform the research and development necessary to generate such a bioink, which we have termed "HeartPrint". HeartPrint bioink fills this important market gap and this project will further enable research and development here in Canada. This Lab to Market project will be conducted by Milena Perez - an award winning biomedical engineer at the University of Victoria - who has already published three well received, peer reviewed journal articles about using 3D bioprinting to produce stem cell-derived tissues. This project will be conducted under the guidance of Dr. Willerth - an internationally recognized expert in 3D printing and tissue engineering.
Program
Idea to Innovation
Recipient
Location
British Columbia, Canada
Recipient Type
Academia
Type
Grant
Source
NSERC's Awards Data
As published
Application id
571266-2022
Name nom
Willerth, Stephanie
Department département
Mechanical Engineering
Organization id
7
Institution établissement
University of Victoria
Province en
British Columbia
Province fr
Colombie-Britannique
Country en
CANADA
Country fr
CANADA
Fiscal year exercice financier
2021
Competition year année de concours
2022
Award amount
20000
Program id
I2IPJ
Program name en
Idea to Innovation
Program name fr
De l'idée à l'innovation
Group en
Research partnerships programs
Group fr
Programmes de partenariat
Committee code
96
Committee name en
RPP Internal Decision Cttee
Committee name fr
Cté de décision interne - PPR
Area of application code
1102
Area of application group en
Health, education and social services
Area of application group fr
Santé publique, éducation et services sociaux
Area of application en
Biomedical engineering
Area of application fr
Génie biomédical
Research subject code
1900
Research subject group en
Biomedical engineering
Research subject group fr
Génie biomédical
Research subject en
Biomedical engineering
Research subject fr
Génie biomédical
Installment
inst:1
Partie
1
Nb partie
1
Application title
Development of HeartPrint Bioink
Keyword
NSERC
Application summary
3D bioprinting enables to generation of human tissue models for screening potential drug targets in a more relevant fashion compared to animal models. Animal models fail to predict the toxicity of potential drug targets on cardiovascular system, including the heart. 40% of drugs that enter clinical trials fail as a result of unexpected cardiotoxicity. Thus, a huge market exists for a bioink capable of printing human cardiac tissues that can be used to screen potential drugs for this issue. This project will upon our team's expertise in producing TissuePrint and BrainPrint to perform the research and development necessary to generate such a bioink, which we have termed "HeartPrint". HeartPrint bioink fills this important market gap and this project will further enable research and development here in Canada. This Lab to Market project will be conducted by Milena Perez - an award winning biomedical engineer at the University of Victoria - who has already published three well received, peer reviewed journal articles about using 3D bioprinting to produce stem cell-derived tissues. This project will be conducted under the guidance of Dr. Willerth - an internationally recognized expert in 3D printing and tissue engineering.